FIBROGEN, INC. FGEN Income Statement

Fibrogen, inc. (FGEN)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue:
Collaboration services and other revenue (includes $1,578, $1,357 and $2,895 from a related party)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,235	16,083	8,544	7,779	6,493	13,671	4,792	5,089	4,635	7,495	3,191
Total revenue
24,401	7,974	33,174	191,566	23,863	108,054	29,027	43,952	31,925	30,736	40,550	30,268	29,442	35,525	30,102	89,280	28,282	24,442	19,538	120,550	16,298	16,105	13,662	89,958	17,876
Operating costs and expenses:
Cost of goods sold
970	-	242	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
54,902	56,798	49,963	52,008	50,496	70,284	56,443	52,138	56,974	52,468	50,336	46,981	46,732	50,606	40,558	52,392	43,650	59,924	52,071	51,555	50,539	51,258	40,617	33,269	25,650
Selling, general and administrative
49,603	50,707	35,823	26,739	22,210	17,851	15,356	15,055	15,550	13,852	12,953	13,425	11,530	12,586	11,646	10,376	11,417	12,965	11,237	9,680	10,482	12,821	10,140	7,516	6,432
Total operating costs and expenses
105,475	108,410	86,028	78,747	72,706	88,135	71,799	67,193	72,524	66,320	63,289	60,406	58,262	63,192	52,204	62,768	55,067	72,889	63,308	61,235	61,021	64,079	50,757	40,785	32,082
Loss from operations
-81,074	-100,436	-52,854	112,819	-48,843	19,919	-42,772	-23,241	-40,599	-35,584	-22,739	-30,138	-28,820	-27,667	-22,102	26,512	-26,785	-48,447	-43,770	59,315	-44,723	-47,974	-37,095	49,173	-14,206
Interest and other, net
Interest expense
633	668	702	736	770	2,733	2,739	2,750	2,769	1,805	2,769	2,757	2,375	2,750	2,760	2,438	2,777	2,755	2,758	2,762	2,758	2,934	2,723	2,725	2,726
Interest income and other, net
3,165	3,053	4,193	4,125	4,177	3,773	3,079	2,645	2,071	3,651	1,106	1,031	645	217	866	129	1,416	113	1,458	707	843	348	283	383	692
Total interest and other, net
2,532	2,385	3,491	3,389	3,407	1,040	340	-105	-698	1,846	-1,663	-1,726	-1,730	-2,533	-1,894	-2,309	-1,361	-2,642	-1,300	-2,055	-1,915	-	-	-	-
Loss before income taxes
-78,542	-98,051	-49,363	116,208	-45,436	20,959	-42,432	-23,346	-41,297	-33,738	-24,402	-31,864	-30,550	-30,200	-23,996	24,203	-28,146	-51,089	-45,070	57,260	-46,638	-50,560	-39,535	46,831	-16,240
Benefit from income taxes
-194	72	76	205	-25	6	124	75	99	156	57	48	60	189	158	-113	-305	280	28	205	-271	0	0	0	0
Net loss
-78,348	-98,123	-49,439	116,003	-45,411	20,953	-42,556	-23,421	-41,396	-33,894	-24,459	-31,912	-30,610	-30,389	-24,154	24,316	-27,841	-51,369	-45,098	57,055	-46,367	-50,560	-39,535	46,831	-16,240
Net loss per share - basic and diluted
-0.89	-	-	-	-0.53	-	-	-	-0.50	-0.40	-0.32	-0.46	-0.48	-	-0.38	-	-0.45	-	-0.74	-	-0.78	-	-2.93	-	-1.23
Weighted average number of common shares used to calculate net loss per share - basic and diluted
88,219	-	-	-	85,704	-	-	-	82,863	82,382	75,891	69,638	64,037	-	62,858	-	62,184	-	60,767	-	59,197	-	13,503	-	13,210
Net income (loss) per share:
Basic
-	-	-0.57	1.34	-	-	-0.50	-0.28	-	-	-	-	-	-	-	0.39	-	-	-	0.95	-	-	-	1.36	-
Diluted
-	-	-0.57	1.26	-	-	-0.50	-0.28	-	-	-	-	-	-	-	0.35	-	-	-	0.83	-	-	-	0.58	-
Weighted average number of common shares used to calculate net income (loss) per share:
Basic
-	-	87,007	86,445	-	-	84,508	83,750	-	-	-	-	-	-	-	62,582	-	-	-	59,798	-	-	-	13,347	-
Diluted
-	-	87,007	91,728	-	-	84,508	83,750	-	-	-	-	-	-	-	69,022	-	-	-	68,752	-	-	-	37,106	-
License Revenue [Member]
Total revenue
0	14,570	11,935	150,581	0	7,946	0	14,323	0	0	9,933	0	0	-63,195	20,867	73,197	19,738	16,663	13,045	106,879	11,506	11,016	9,027	82,463	14,685
Development and Other Revenue [Member]
Total revenue
19,446	28,607	20,660	40,985	23,863	35,332	29,027	29,629	31,925	30,736	30,617	30,268	29,442	-	-	-	-	-	-	-	-	-	-	-	-
Product Revenue, Net [Member]
Total revenue
4,955	-	579	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-